Control of cell proliferation via elevated NEDD8 conjugation in oral squamous cell carcinoma
- PMID: 17660949
- DOI: 10.1007/s11010-007-9566-7
Control of cell proliferation via elevated NEDD8 conjugation in oral squamous cell carcinoma
Abstract
A prominent feature of all cancers including oral carcinoma is an abnormality in cellular proliferation. Neural precursor cell-expressed developmentally down-regulated 8 (NEDD8) is a ubiquitin-like protein exerting its biological function through covalent ligation to a family of cullin proteins, which act as a component of the Skp1, cullin, and F-box protein complex that plays a critical role in the regulation of cell cycle. Using Western blot analysis, an increase in NEDD8 conjugation was observed in all highly proliferative cells, including immortalized normal oral keratinocyte (NOK), oral-derived carcinoma (KB, HSC4), and several types of human carcinoma cell lines as compared to normal human gingival fibroblast. The level of NEDD8 conjugation was proportionally dependent on the concentration of serum in culture medium, which also affected proliferation status of oral squamous cell carcinoma. NEDD8 conjugation was required for proliferation of the carcinoma cell since the transfection of dominant negative Ubc12 (Ubc12C111S) could prolong the rate of proliferation. Taken together, up-regulation of the NEDD8 conjugation is an essential requirement for the enhancement of proliferation of oral carcinoma cells.
Similar articles
-
Inhibition of the NEDD8 conjugation pathway by shRNA to UBA3, the subunit of the NEDD8-activating enzyme, suppresses the growth of melanoma cells.Asian Pac J Cancer Prev. 2012;13(1):57-62. doi: 10.7314/apjcp.2012.13.1.057. Asian Pac J Cancer Prev. 2012. PMID: 22502714
-
In vitro systems for NEDD8 conjugation by Ubc12.Methods Enzymol. 2005;398:68-73. doi: 10.1016/S0076-6879(05)98007-5. Methods Enzymol. 2005. PMID: 16275320
-
A lysine-to-arginine mutation on NEDD8 markedly reduces the activity of cullin RING E3 ligase through the impairment of neddylation cascades.Biochem Biophys Res Commun. 2015 Jun 12;461(4):653-8. doi: 10.1016/j.bbrc.2015.04.085. Epub 2015 Apr 24. Biochem Biophys Res Commun. 2015. PMID: 25918018
-
Nedd8 on cullin: building an expressway to protein destruction.Oncogene. 2004 Mar 15;23(11):1985-97. doi: 10.1038/sj.onc.1207414. Oncogene. 2004. PMID: 15021886 Review.
-
Novel substrates and functions for the ubiquitin-like molecule NEDD8.Biochem Soc Trans. 2008 Oct;36(Pt 5):802-6. doi: 10.1042/BST0360802. Biochem Soc Trans. 2008. PMID: 18793140 Review.
Cited by
-
Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy.Mol Oncol. 2012 Jun;6(3):267-75. doi: 10.1016/j.molonc.2012.01.003. Epub 2012 Jan 21. Mol Oncol. 2012. PMID: 22306028 Free PMC article. Review.
-
Targeting cullin neddylation for cancer and fibrotic diseases.Theranostics. 2023 Sep 4;13(14):5017-5056. doi: 10.7150/thno.78876. eCollection 2023. Theranostics. 2023. PMID: 37771770 Free PMC article. Review.
-
CSN complex controls the stability of selected synaptic proteins via a torsinA-dependent process.EMBO J. 2011 Jan 5;30(1):181-93. doi: 10.1038/emboj.2010.285. Epub 2010 Nov 19. EMBO J. 2011. PMID: 21102408 Free PMC article.
-
Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.Antioxid Redox Signal. 2014 Dec 10;21(17):2383-400. doi: 10.1089/ars.2013.5795. Epub 2014 Feb 20. Antioxid Redox Signal. 2014. PMID: 24410571 Free PMC article. Review.
-
Uncovering ubiquitin and ubiquitin-like signaling networks.Chem Rev. 2011 Dec 14;111(12):7923-40. doi: 10.1021/cr200187e. Epub 2011 Oct 17. Chem Rev. 2011. PMID: 22004258 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous